Clinical and Inflammatory Phenotyping: Can Electronic Nose and NMR-based Metabolomics Work at the Bedside?

Mauro Maniscalco, Andrea Motta

Research output: Contribution to journalArticle

Abstract

Electronic nose (eNose) and nuclear magnetic resonance (NMR)-based metabolomics seem to be able to identify metabolic and inflammatory profiles in patients with chronic obstructive diseases. The hypothesis arises from three recent studies using two different methods in patients with asthma and chronic obstructive pulmonary diseases (COPD), opening promising diagnostic perspectives. The possibility that the use of eNose and NMR-based metabolomics might provide clinical/inflammatory characteristics is intriguing. This might classify specific phenotypes of chronic airway disease regardless of the diagnosis asthma or COPD, therefore suggesting therapeutical targets for a personalized respiratory medicine through more efficient "tailored" strategies.

Original languageEnglish
Pages (from-to)74-76
Number of pages3
JournalArchives of Medical Research
Volume49
Issue number1
DOIs
Publication statusPublished - Jan 2018

Fingerprint Dive into the research topics of 'Clinical and Inflammatory Phenotyping: Can Electronic Nose and NMR-based Metabolomics Work at the Bedside?'. Together they form a unique fingerprint.

  • Cite this